Pet Drug Reports

Oxytetracycline Dihydrate: adverse event reports in all combinations

Active ingredient, alone and in combinations

Brand names with this ingredient: Noromycin 300 LA, Agrimycin 200, Terramycin.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Read this first. FDA says this about the data:

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .

This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.

Contacting a veterinarianHow to report to FDA

FDA reports received through . Counts include this ingredient alone and in combinations. Why brand names have no separate count.

From May 2011 to April 2026, FDA received 389 adverse event reports that name a drug with oxytetracycline dihydrate, alone or in a combination. 2 sets of active ingredients with oxytetracycline dihydrate have a drug page.

Of the 389 reports, 164 (42.2%) are about cattle. 34 reports are about people who were exposed to the drug (8.7%). In January to March 2026, FDA received 4 reports that name oxytetracycline dihydrate, alone or in a combination. The signs that appear in the largest number of the 389 reports are "Death" and "Vials, Damaged". A report is not proof that a drug caused a sign.

Reports that name this ingredient fell by 27.3% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about dogs are 5.1% of the reports that name this ingredient, and 72.6% of all reports.

Search engines list an ingredient page with 500 reports or more in all years. The page also needs 30 reports or more in the 12 months to June 2026. This page is under one of these numbers. The site keeps the page and keeps it out of search engines.

Reports in the latest closed quarter

Reports that name oxytetracycline dihydrate, by the quarter in which FDA received them
SpeciesJan to Mar 2026Oct to Dec 2025Jan to Mar 2025
All species472
Dog000
Cat000
Horse020
Other or not given452

January to March 2026 is the latest closed quarter in the data.

All updatesFeed of updates (RSS)

Drug pages with oxytetracycline dihydrate

A report names a drug by its set of active ingredients. Each set with oxytetracycline dihydrate that has a drug page is in the table, in order of name. The table has 2 sets.

Drug pages with oxytetracycline dihydrate, in order of name, with the reports of each page
Active ingredientsReports, all yearsReports, latest 12 months
Oxytetracycline + Oxytetracycline Dihydrate1653
Oxytetracycline Dihydrate22213

A report can name more than one set, so the counts of the sets can add to more than the count of the page.

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

Signs that the reports list

A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 389 reports that list the sign. One report can list more than one sign and more than one drug.

The sign that is in the largest number of the reports comes first.

  1. Death17.5%68 reports
  2. Vials, Damaged[a product quality report, not a sign in an animal]13.6%53 reports
  3. Injection site swelling[swelling where the injection was given]7.2%28 reports
  4. Lack of efficacy (bacteria) - NOS[the product did not have the expected effect: target not specified]7.2%28 reports
  5. Lack of efficacy - NOS[the product did not have the expected effect]7.2%28 reports
  6. Anaphylaxis[sudden severe allergic-type reaction]6.2%24 reports
  7. Bottles, Damaged[a product quality report, not a sign in an animal]4.6%18 reports
  8. Injection site pain[pain where the injection was given]4.4%17 reports
  9. Accidental exposure[exposure that was not intended]3.9%15 reports
  10. Color, Abnormal[a product quality report, not a sign in an animal]3.9%15 reports
  11. Containers, Damaged[a product quality report, not a sign in an animal]3.9%15 reports
  12. Containers, Leaking[a product quality report, not a sign in an animal]3.9%15 reports
  13. Anorexia[not eating]2.8%11 reports
Show the next 16 signs
  1. Foaming at the mouth2.8%11 reports
  2. Sudden death2.8%11 reports
  3. Lethargy[unusually tired or inactive]2.6%10 reports
  4. Appearance, Abnormal[a product quality report, not a sign in an animal]2.3%9 reports
  5. Uncoded sign[a sign with no matching dictionary term]2.3%9 reports
  6. Death by euthanasia[the animal was euthanized]2.1%8 reports
  7. Injection site inflammation[inflammation where the injection was given]2.1%8 reports
  8. Collapse NOS[NOS: not otherwise specified]1.8%7 reports
  9. Injection site reaction NOS[reaction nos where the injection was given]1.8%7 reports
  10. No sign[no clinical sign was reported]1.8%7 reports
  11. Product Defect, General[a product quality report, not a sign in an animal]1.8%7 reports
  12. Behavioural disorder NOS[behaviour change, type not specified]1.5%6 reports
  13. Ineffective, antibiotic[legacy FDA term: the product did not have the expected effect (antibiotic)]1.5%6 reports
  14. Injection site bleeding[bleeding where the injection was given]1.5%6 reports
  15. Injection site lump[lump where the injection was given]1.5%6 reports
  16. Localised pain NOS[NOS: not otherwise specified]1.5%6 reports

Download all signs (CSV)

Reports by species

Reports for each month, Jul 2021 to Jun 2026

Dog6 reports

No chart: no month has 5 or more reports.

Cat3 reports

No chart: no month has 5 or more reports.

Horse7 reports

No chart: no month has 5 or more reports.

Other or not given117 reports. Largest count in one month: 7 (Jul 2024)

The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

Reports by year

  • Dog
  • Cat
  • Horse
  • Other or not given
Reports that name oxytetracycline dihydrate, by the year in which FDA received them and by species
YearDogCatHorseOther or not givenAll species
202600055
20250031417
20240102728
20232202327
20223042835
20211013537
20202025155
20190025456
20181112629
20175011824
20160001717
2015021912
20141001415
20132001315
20123001215
201100022

2026 has the reports that FDA received through Apr 2026. Download the years (CSV)

What the reports record

Outcome at the time of the report

  • Recovered/Normal19.5%76
  • Recovered with Sequela[recovered, with a lasting effect]0.3%1
  • Ongoing6.9%27
  • Died22.9%89
  • Euthanized2.1%8
  • Outcome Unknown26%101

An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 389 reports that name oxytetracycline dihydrate.

Kind of report

  • Safety issue51.7%201
  • Lack of expected effectiveness9%35
  • Both safety and lack of expected effectiveness4.6%18
  • Manufacturing or product defect34.7%135
  • Other0%0

Age of the animal

  • Under 1 year14.1%55
  • 1 to 3 years13.1%51
  • 4 to 7 years4.6%18
  • 8 to 11 years1.8%7
  • 12 years and over9.8%38
  • Age not given56.6%220

Each share of kind and age is of the 389 reports that name oxytetracycline dihydrate.

Approved animal drugs with this active ingredient (FDA Green Book)

This section is reference data. It has no report count.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Brand names

  • Noromycin 300 LA
  • Agrimycin 200
  • Terramycin

What the Green Book records give

Applications with an approval in force
3
Approved species
Cattle, Crustaceans, Fish, Swine
Dose forms
Type A Medicated Article, Injectable Solution, Solution
Routes
Intramuscular, Intravenous, Oral, Subcutaneous
Sale
RX (prescription), VFD (veterinary feed directive)
Earliest approval date in the records

The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.

Applications in the Green Book of 2 Nov 2026, pioneer applications (NADA) first
Brand nameActive ingredientsSponsorApproved speciesApplication
Terramycin 100 for Fish; Terramycin 200 for FishOxytetracycline DihydratePhibro Animal Health Corp.Not in the list of major speciesNADA 038-439
Noromycin 300 LAOxytetracycline DihydrateNorbrook Laboratories, Ltd.Cattle, SwineNADA 141-143
Agrimycin 200Oxytetracycline DihydrateHuvepharma EOODCattle, SwineANADA 200-128

FDA pages for this ingredient

The site checked these addresses on . The links open in a new tab.

Cite this page

Pet Drug Reports. Oxytetracycline Dihydrate, all combinations: adverse event reports that FDA received. https://petdrugreports.com/ingredient/oxytetracycline-dihydrate/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .

Where the data come from

The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. Ingredient names follow the Green Book, with salts and forms as FDA lists them.

The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.

Questions about these reports

Which brand are these reports about?

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists brand names with this active ingredient.

Do the reports show that the ingredient caused the signs?

No. A report can name more than one drug, and a drug can have more than one active ingredient. FDA states this about the data.

When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.

The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

How many reports did FDA receive in the latest 12 months?

FDA received 16 reports in the 12 months to June 2026. It received 22 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

What kinds of report are in the count?

Of the 389 reports received from May 2011 to April 2026, 51.7% are about a safety issue only. 13.6% are about a lack of expected effectiveness, alone or with a safety issue. 34.7% are about a defect of the product or its package.